West to Present at Barclays Conference
Get Alerts WST Hot Sheet
Join SI Premium – FREE
EXTON, PA -- (Marketwired) -- 03/05/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at the Barclays Global Healthcare Conference, Miami, FL at 2:05 p.m. ET on Thursday, March 12th, 2015.
A live audio webcast of the presentation, as well as the presentation materials, will be accessible from the Company's website at www.westpharma.com/en/investors.
About West West Pharmaceutical Services is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2014 sales of $1.42 billion reflect the daily use of approximately 110 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world. www.westpharma.com
West and the diamond logo and By your side for a healthier world" are registered trademarks or trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
Contacts: West Michael A. Anderson Vice President and Treasurer (610) 594-3345 Investors and Financial Media: Westwicke Partners John Woolford (443) 213-0506
Source: West Pharmaceutical Services, Inc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- West Pharma (WST) Tops Q1 EPS by 26c, provides guidance
- Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
- Macerich Celebrates Earth Month With ‘You Pledge We Plant’ Campaign, Industry Recognition
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!